1. Leishmaniasis – Authors' reply. Issue 10174 (2nd March 2019) Authors: Burza, Sakib; Croft, Simon L; Boelaert, Marleen Journal: Lancet Issue: Volume 393:Issue 10174(2019) Page Start: 872 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Leishmaniasis. Issue 10151 (15th September 2018) Authors: Burza, Sakib; Croft, Simon L; Boelaert, Marleen Journal: Lancet Issue: Volume 392:Issue 10151(2018) Page Start: 951 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Leishmaniasis: new approaches to disease control. Issue 7385 (15th February 2003) Authors: Davies, Clive R; Kaye, Paul; Croft, Simon L; Sundar, Shyam Journal: BMJ Issue: Volume 326:Issue 7385(2003) Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacodynamics and cellular accumulation of amphotericin B and miltefosine in Leishmania donovani-infected primary macrophages. (28th February 2018) Authors: Voak, Andrew A; Standing, Joseph F; Sepúlveda, Nuno; Harris, Andy; Croft, Simon L; Seifert, Karin Journal: Journal of antimicrobial chemotherapy Issue: Volume 73:Number 5(2018) Page Start: 1314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model. (27th May 2016) Authors: Van Bocxlaer, Katrien; Yardley, Vanessa; Murdan, Sudaxshina; Croft, Simon L Journal: Journal of pharmacy and pharmacology Issue: Volume 68:Number 7(2016:Jul.) Page Start: 862 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗